JPH0622628B2 - Carrier for immobilization of physiologically active substance and method for producing the same - Google Patents
Carrier for immobilization of physiologically active substance and method for producing the sameInfo
- Publication number
- JPH0622628B2 JPH0622628B2 JP60199395A JP19939585A JPH0622628B2 JP H0622628 B2 JPH0622628 B2 JP H0622628B2 JP 60199395 A JP60199395 A JP 60199395A JP 19939585 A JP19939585 A JP 19939585A JP H0622628 B2 JPH0622628 B2 JP H0622628B2
- Authority
- JP
- Japan
- Prior art keywords
- carrier
- fiber
- physiologically active
- active substance
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013543 active substance Substances 0.000 title claims description 12
- 238000004519 manufacturing process Methods 0.000 title description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 19
- 125000000524 functional group Chemical group 0.000 claims description 18
- 229920002554 vinyl polymer Polymers 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 229910021529 ammonia Inorganic materials 0.000 claims description 9
- 239000003495 polar organic solvent Substances 0.000 claims description 8
- 150000004985 diamines Chemical class 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 230000003100 immobilizing effect Effects 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 239000000835 fiber Substances 0.000 description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 8
- -1 polypropylene Polymers 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000002522 swelling effect Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- TXNSZCSYBXHETP-UHFFFAOYSA-N 2-chloro-n-(hydroxymethyl)acetamide Chemical compound OCNC(=O)CCl TXNSZCSYBXHETP-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- DWBZUUKLOFQIGX-UHFFFAOYSA-N azane;methylsulfinylmethane Chemical compound N.CS(C)=O DWBZUUKLOFQIGX-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- KSSNXJHPEFVKHY-UHFFFAOYSA-N phenol;hydrate Chemical compound O.OC1=CC=CC=C1 KSSNXJHPEFVKHY-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920013639 polyalphaolefin Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、生理活性物質の固定化用担体およびその製法
に関する。TECHNICAL FIELD The present invention relates to a carrier for immobilizing a physiologically active substance and a method for producing the same.
(従来の技術) 生理活性物質を不溶性担体に固定化したものはアフィニ
ティークロマトグラフ用吸着剤、固定化酵素、治療用血
液浄化剤、治療用イミュノモジュレーター、抗菌剤その
他分析用試薬として広く利用されており、今後さらに幅
広い展開が期待される重要な物質である。(Prior Art) A substance in which a physiologically active substance is immobilized on an insoluble carrier is widely used as an adsorbent for affinity chromatography, immobilized enzyme, therapeutic blood purification agent, therapeutic immunomodulator, antibacterial agent and other analytical reagents. It is an important substance that is expected to expand further in the future.
固定化用担体として具備すべき要件は、(1)使用条件に
おいて、機械的、化学的および熱的に安定であること、
(2)生理活性物質を密度高く固定化できること、(3)製造
が容易であること、(4)加水分解酵素によって短時間に
分解されないことなどである。The requirements to be provided as an immobilization carrier are (1) under the conditions of use, be mechanically, chemically and thermally stable,
(2) It is possible to immobilize a physiologically active substance at a high density, (3) it is easy to manufacture, and (4) it is not decomposed by a hydrolase in a short time.
固定化用担体の例としては、セファローズ、アガロース
などの多糖類ゲルをブロムシアン化したもの、多孔性シ
リカゲルビーズをブロムシアン化したもの、架橋ポリア
クリルアミドビーズなどが知られているが、多糖類ゲル
は含水度が高すぎて、通液性が悪く、とりわけ血液のよ
うな高粘性液体では使いにくい。さらに化学的にも不安
定である。多孔性シリカゲルビーズや架橋ポリアクリル
アミドビーズなどでは固定化密度が低く、また、化学的
安定性も低い欠点がある。As examples of the carrier for immobilization, sepharose, those obtained by bromocyanating polysaccharide gel such as agarose, those obtained by bromocyanating porous silica gel beads, crosslinked polyacrylamide beads, etc. are known, but the polysaccharide gel is The water content is too high and the liquid permeability is poor, and it is especially difficult to use with highly viscous liquids such as blood. Furthermore, it is chemically unstable. Porous silica gel beads and cross-linked polyacrylamide beads have the drawbacks of low immobilization density and low chemical stability.
そのほか、これらの欠点を改良したものとして、本発明
者らが提供した繊維状担体(エチレンジアミノアセトア
ミドメチル化ポリスチレン繊維;特開昭59−6405
3)がある。これは化学的および熱的にも安定であり、
上記担体に比べ、固定化密度の高い利点があるものの、
pH変動に対する体積変化が大きい欠点がある。例え
ば、pHが7.4から4.0に変るとその含水率(担体
1gに含まれる水のグラム数)が6倍にもなる(実施例
4、比較繊維5)。成型品で体積変化が大きいと自己破
壊が起りやすく、また、カラムに充填して使用するとき
は、再使用の繰返しによって偏流が起りやすくなる欠点
がある。In addition, as a modification of these drawbacks, a fibrous carrier provided by the present inventors (ethylenediaminoacetamidomethylated polystyrene fiber; JP-A-59-6405).
There is 3). It is chemically and thermally stable,
Although it has the advantage of high immobilization density compared to the above carrier,
There is a drawback that the volume change is large with respect to the pH change. For example, when the pH is changed from 7.4 to 4.0, the water content (the number of grams of water contained in 1 g of the carrier) becomes 6 times (Example 4, Comparative Fiber 5). If the molded product has a large volume change, it tends to cause self-destruction, and when it is packed in a column and used, a drift tends to occur due to repeated reuse.
固定化用担体と被固定化物質の間の結合としてはアミド
結合、アルキル結合、エーテル結合、エステル結合、ウ
レイド結合、尿素結などが知られているが、これらのな
かでアミド結合とアルキル結合の化学的安定性が高い。
とくにアミド結合は適用できる被固定化物質の範囲が広
く、固定化条件も穏やかなので好んで使われる。従っ
て、担体に保持させるべき官能基には、アミド結合を形
成しうる脂肪族第一級アミノ基もしくはカルボキシル基
がもっとも好んで用いられる。脂肪族第二級アミノ基や
芳香族第一級アミノ基も使用できるが、反応速度が小さ
いので、一般的にあまり用いられていない。As the bond between the immobilizing carrier and the substance to be immobilized, an amide bond, an alkyl bond, an ether bond, an ester bond, a ureido bond, a urea bond and the like are known. Among these, the amide bond and the alkyl bond are known. High chemical stability.
Especially, the amide bond is preferably used because the range of applicable substances to be immobilized is wide and the immobilization condition is mild. Therefore, an aliphatic primary amino group or a carboxyl group capable of forming an amide bond is most preferably used as the functional group to be retained on the carrier. Aliphatic secondary amino groups and aromatic primary amino groups can also be used, but they are generally not widely used because of the low reaction rate.
(発明が解決しようとする問題点) 本発明は、かかる従来技術の問題点解消を図るべく鋭意
検討を行なった結果、本発明に到達した。(Problems to be Solved by the Invention) The present invention has reached the present invention as a result of extensive studies to solve the problems of the conventional art.
(問題点を解決するための手段) 本発明は、 (1)側鎖として、下記一般式(I)で示される官能基を
導入した芳香核を有するビニル系重合体からなる生理活
性物質の固定化用担体。(Means for Solving Problems) The present invention provides (1) immobilization of a physiologically active substance composed of a vinyl polymer having an aromatic nucleus into which a functional group represented by the following general formula (I) is introduced as a side chain. Chemical carrier.
(上式中、R1、R2は水素原子または低級アルキル基
を示し、R3はNH2またはNH−R4−NH2基、R
4は炭素数4以上16以下のアルキレン基を示す) (2)側鎖として下記一般式(II)で示される官能基を導
入した芳香核を有するビニル系重合体およびその成型品
をアンモニア、 (上式中、R1、R2は水素原子または低級アルキル基
を、Xはハロゲン原子を示す)下記一般式(III)で示
されるジアミンと反応させる際、 NH2−R4−NH2基 (III) (R4は炭素数4以上16以下のアルキレン基を示す) 非プロトン性極性有機溶媒を用いることを特徴とする生
理活性物質の固定化用担体の製法。 (In the above formula, R 1 and R 2 represent a hydrogen atom or a lower alkyl group, R 3 represents an NH 2 or NH—R 4 —NH 2 group, R 3
4 represents an alkylene group having 4 to 16 carbon atoms. (2) A vinyl polymer having an aromatic nucleus in which a functional group represented by the following general formula (II) is introduced as a side chain and a molded product thereof are ammonia, (In the above formula, R 1 and R 2 are hydrogen atoms or lower alkyl groups, and X is a halogen atom.) When reacting with a diamine represented by the following general formula (III), an NH 2 —R 4 —NH 2 group (III) (R 4 represents an alkylene group having 4 to 16 carbon atoms) An aprotic polar organic solvent is used to produce a carrier for immobilizing a physiologically active substance.
を提供するものである。Is provided.
本発明でいう芳香核を有するビニル系重合体とはスチレ
ン、αメチルスチレン、ビニルトルエンなどで代表され
る芳香核を有するビニル系モノマの単独重合体もしくは
これらを主成分とする共重合体を意味し、これらの重合
体は架橋されていればさらに好ましい。また該重合体は
結晶性ポリプロピレン、ポリエチレンなどで代表される
ポリα−オレフインで補強されていれば、機械的性質が
向上するので、さらに好ましい。例えば、ジビニルベン
ゼンあるいはメチレンビスアクリルアミド等で代表され
るポリビニル化合物との共重合体のほか、上記モノビニ
ル化合物重合体成形品をホルムアルデヒド、クロルスル
ホン酸等で架橋処理したもの等があげられる。架橋重合
体は流動性がなく、成形が困難なので、該重合体成形品
が繊維、膜等の場合は成形後架橋処理する方法が好まし
く採用される。The vinyl polymer having an aromatic nucleus in the present invention means a homopolymer of a vinyl monomer having an aromatic nucleus represented by styrene, α-methylstyrene, vinyltoluene or the like or a copolymer containing these as the main components. However, it is more preferable that these polymers are crosslinked. Further, if the polymer is reinforced with poly α-olefin represented by crystalline polypropylene, polyethylene, etc., the mechanical properties are improved, which is more preferable. Examples thereof include a copolymer with a polyvinyl compound represented by divinylbenzene or methylenebisacrylamide, and a product obtained by subjecting the molded product of the above-mentioned monovinyl compound to a cross-linking treatment with formaldehyde, chlorosulfonic acid or the like. Since the crosslinked polymer has no fluidity and is difficult to mold, when the polymer molded product is a fiber, a film or the like, a method of crosslinking after molding is preferably adopted.
本発明でいう成型品とは繊維、膜、中空糸、直径10μ
m以上の粒状物およびびそれらの高次加工品を意味す
る。とりわけ、繊維、中空糸が流路を確保できる使用形
態にできるので良い。この特性は固定化物を血液のよう
な高粘性液体の処理剤として使用するとき重要である。Molded product in the present invention means fiber, membrane, hollow fiber, diameter 10μ
It means granules of m or more and their higher-order processed products. In particular, it is preferable that fibers and hollow fibers can be used in such a manner that a flow path can be secured. This property is important when the immobilizate is used as a treatment agent for highly viscous liquids such as blood.
本発明成形品の表面積はあまり小さすぎると、生理活性
物質を密度高く固定化できなくなるが、あまり大きすぎ
ても、本発明成形品を充填したカラムの通液性は悪くな
るので、該成形品の表面積は0.01以上50m2/g
以下、より好ましくは、0.05以上10m2/g以下
がよい。If the surface area of the molded article of the present invention is too small, it will not be possible to immobilize the physiologically active substance at a high density, but if it is too large, the liquid permeability of the column packed with the molded article of the present invention will deteriorate. Surface area of 0.01 or more 50m 2 / g
Hereafter, it is more preferably 0.05 or more and 10 m 2 / g or less.
本発明重合体および成型品の膨潤性は生理活性物質の固
定化能を左右する重要な因子である。膨潤性が大きすぎ
ると、固定化密度は増大するが、機械的性質が悪くな
り、また、逆に小さすぎると固定化密度が減少するの
で、含水率は成型品1gあたり0.6〜3.0gとりわ
け1.0〜2.0gがよい。The swelling properties of the polymer and the molded product of the present invention are important factors that affect the ability to immobilize physiologically active substances. If the swelling property is too large, the immobilization density will increase, but the mechanical properties will deteriorate, and if it is too small, the immobilization density will decrease, so the water content will be 0.6 to 3. 0 g, especially 1.0 to 2.0 g is preferable.
本発明でいう前記官能基一般式(I)および(II)中の
R1、R2は水素原子または低級アルキル基であればよ
く、とくに限定はないが、官能基が炭素数の少ない官能
基であると、とりわけ、水素原子であると、立体障害が
少ないので、つくりやすい、また固定化密度を高くでき
る長所がある。R 1 and R 2 in the functional groups (I) and (II) in the present invention are not particularly limited as long as they are hydrogen atoms or lower alkyl groups, but the functional groups are functional groups having a small number of carbon atoms. In particular, a hydrogen atom has less steric hindrance, which is advantageous in that it is easy to prepare and the immobilization density can be increased.
本発明でいう前記官能基一般式(I)中のR3がNH2
であるときは、安価で簡単に製造できる利点があり、か
つ、固定化後に残る余分のアミノ基が少ないので、固定
化物を生体に対し使用するときの生体適合性が良く、ま
た、それ以外の用途に使うときもイオン的影響が少ない
ので好ましい。また、官能基一般式(I)中のR3がN
H−R4−NH2であるときは、R4の炭素数は少なす
ぎると、アルキル基に対するアミノ基の比率が高くなっ
て、担体のイオン的性質が強くなりすぎたり、着色しや
すくなるので好ましくない。一方、R4の炭素数は多す
ぎると、担体の疎水性が強くなりすぎて、固定化密度が
小さくなる欠点がある。従って、R4の炭素数は4以
上、16以下が好ましい。R4の具体例としてはヘキサ
メチレン基、ドデカメチレン基、ウンデカメチレン基な
どがあり、これらはとくに安価で、入手しやすい。その
他、2−メチルヘキサメチレン基などの枝分かれしたも
のも使用できる。In the general formula (I) for the functional group in the present invention, R 3 is NH 2
When it is, there is an advantage that it can be easily manufactured at low cost, and since there are few extra amino groups remaining after immobilization, it has good biocompatibility when the immobilized product is used for a living body, and It is preferable because it has little ionic effect when used for applications. In addition, R 3 in the functional group general formula (I) is N
In the case of H—R 4 —NH 2 , if the carbon number of R 4 is too small, the ratio of amino groups to alkyl groups becomes high, and the ionic properties of the carrier become too strong, or coloring easily occurs. Not preferable. On the other hand, if the carbon number of R 4 is too large, there is a drawback that the carrier becomes too hydrophobic and the immobilization density becomes small. Therefore, the carbon number of R 4 is preferably 4 or more and 16 or less. Specific examples of R 4 include a hexamethylene group, a dodecamethylene group, and an undecamethylene group, which are particularly inexpensive and easily available. In addition, a branched one such as a 2-methylhexamethylene group can also be used.
本発明でいう非プロトン性極性有機溶媒とは誘電率が1
5以上の非プロトン性極性有機溶媒を意味する。その具
体例としてジメチルスルホキシド、N,N−ジメチルホ
ルムアミド、N,N−ジメチルアセトアミド、ヘキサメ
チルホスホルアミド、テトラメチル尿素等をあげること
ができる。また、非プロトン性極性有機溶媒以外の溶媒
との併用も可能である。非プロトン性極性有機溶媒の使
用量は多いほど膨潤性の高い本発明成型品がえられる
が、通常、原料の重合体およびその成型品の1gあたり
1g以上、より好ましくは、100g以上用いられる。The aprotic polar organic solvent referred to in the present invention has a dielectric constant of 1
Means 5 or more aprotic polar organic solvents. Specific examples thereof include dimethyl sulfoxide, N, N-dimethylformamide, N, N-dimethylacetamide, hexamethylphosphoramide, tetramethylurea and the like. Further, it can be used in combination with a solvent other than the aprotic polar organic solvent. The larger the amount of the aprotic polar organic solvent used, the higher the swelling property of the molded product of the present invention is, but usually 1 g or more, and more preferably 100 g or more per 1 g of the raw material polymer and the molded product.
本発明成型品の製造は、特許請求範囲第一項記載の一般
式(II)で示される官能基を導入した芳香核を有するビ
ニル系重合体およびその成型品すなわちα−ハロアセト
アミドメチル化芳香族ビニル系重合体およびその成型品
(特開昭57−12008)をアンモニアもしくは一般
式(III)で示されるジアミンを含む非プロトン性極性
溶媒の溶液に浸漬するか、この原料成型品をあらかじめ
非プロトン性極性有機溶媒で膨潤させてからアンモニア
もしくは一般式(III)で示されるジアミンと接触させ
ることにより達成できる。The molded product of the present invention is produced by a vinyl polymer having an aromatic nucleus having a functional group represented by the general formula (II) described in claim 1 and a molded product thereof, that is, an α-haloacetamidomethylated aromatic compound. The vinyl polymer and its molded product (Japanese Patent Laid-Open No. 57-12008) are immersed in a solution of an aprotic polar solvent containing ammonia or a diamine represented by the general formula (III), or this raw material molded product is previously treated with an aprotic compound. It can be achieved by swelling with a polar organic solvent and then contacting with ammonia or the diamine represented by the general formula (III).
本発明で用いるアンモニアおよび一般式(III)で示さ
れるジアミンの量は、少なすぎると架橋反応が優先して
おこり、得られる担体の膨潤性が低くなりすぎるので、
α−ハロアセトアミドメチル化芳香族ビニル系重合体の
α−ハロアセトアミドメチル基に対し等モル以上、とり
わけ、5倍モル以上用いることが好ましい。The amount of ammonia and the diamine represented by the general formula (III) used in the present invention, when the amount is too small, the crosslinking reaction occurs preferentially, and the swelling property of the obtained carrier becomes too low,
It is preferable to use an equimolar amount or more, especially 5 times or more moles, with respect to the α-haloacetamidomethyl group of the α-haloacetamidomethylated aromatic vinyl polymer.
溶液中のアンモニアの濃度は高いど膨潤性の大きな担体
を作ることができる。溶液中のアンモニアの濃度は低す
ぎると、膨潤性の小さな担体しか作ることかできないの
で、0.5%以上、とりわけ、2.0%以上が好まし
い。一方、溶液中のジアミンの濃度が高すぎると、一般
式(II)で示される官能基を導入した芳香核を有するビ
ニル系重合体およびその成型品に対する溶液の膨潤力が
落ちてしまうので、0.5%以上、50%以下、とりわ
け、2.0%以上、20%以下が好ましい。The higher the concentration of ammonia in the solution, the more swellable the carrier can be made. If the concentration of ammonia in the solution is too low, only a carrier having a small swelling property can be produced, so 0.5% or more, particularly 2.0% or more is preferable. On the other hand, if the concentration of the diamine in the solution is too high, the swelling power of the solution with respect to the vinyl polymer having a functional group-introduced aromatic nucleus represented by the general formula (II) and the molded article thereof will decrease. 0.5% or more and 50% or less, especially 2.0% or more and 20% or less are preferable.
また、反応の温度は通常0〜100℃、とりわけ、0〜
30℃が好ましく用いられる。反応の温度が低いと膨潤
性の大きな担体がえられる。The reaction temperature is usually 0 to 100 ° C., especially 0 to
30 ° C. is preferably used. When the reaction temperature is low, a carrier having a large swelling property can be obtained.
本発明重合体およびその成型品は、生理活性物質の固定
化用担体として使用される。The polymer of the present invention and its molded product are used as a carrier for immobilizing a physiologically active substance.
(発明の効果) 本発明重合体およびその成型品は、長い鎖の先端に固定
化する官能基を持っているので、生理活性物質を密度高
く固定化することができる。また、膨潤性に関してpH
依存性が小さいので使いやすく、丈夫である。(Effect of the invention) Since the polymer of the present invention and the molded product thereof have a functional group that is immobilized on the tip of a long chain, a physiologically active substance can be immobilized at a high density. In addition, regarding swellability, pH
It is easy to use and durable because it has little dependence.
本発明重合体の官能基(I)は固定化処理後、残余のア
ミノ基をアシル化して消滅させることができ、その結
果、生理活性物質固定化物を中性に変換できる利点があ
る。The functional group (I) of the polymer of the present invention has an advantage that after the immobilization treatment, the remaining amino groups can be acylated and eliminated, and as a result, the physiologically active substance-immobilized product can be converted to neutral.
また、本発明重合体の官能基(I)は無水コハク酸など
のジカルボン酸無水物で開環アシル化して、容易にカル
ボキシル基をもつ担体に変換できる利点がある。Further, the functional group (I) of the polymer of the present invention has an advantage that it can be easily converted into a carrier having a carboxyl group by ring-opening acylation with a dicarboxylic acid anhydride such as succinic anhydride.
本発明の重合体を得る反応は、概念的には一般式(II)
で示される官能基を導入した芳香核を有するビニル系重
合体またはその成型品をアンモニアまたは一般式(II
I)で示されるジアミンと反応させれば良いはずである
が、これらアミノ化合物が多価反応性であるために架橋
反応が起り、低膨潤性の重合体または成型品しかえられ
ない。この架橋反応を防止するためにはアミノ化合物の
濃度を上げることがこの改善策の一つであるが、溶解度
に制約があったり、高価であったりして好ましくない。
ところが、本発明の方法を用いれば、アミノ化合物の濃
度が低くても膨潤性の高い担体をつくりうるので経済的
である。The reaction for obtaining the polymer of the present invention is conceptually represented by the general formula (II)
A vinyl polymer having an aromatic nucleus having a functional group introduced therein or a molded product thereof is treated with ammonia or the general formula (II
It should be allowed to react with the diamine represented by I), but since these amino compounds are polyvalent reactive, a crosslinking reaction occurs and only a low swelling polymer or molded product is obtained. In order to prevent the crosslinking reaction, increasing the concentration of the amino compound is one of the improvement measures, but it is not preferable because the solubility is limited or the cost is high.
However, the use of the method of the present invention is economical because a carrier having a high swelling property can be prepared even when the concentration of the amino compound is low.
(実施例) 以下に実施例を示す。(Example) An example is shown below.
実施例1 ポリプロピレン(三井“ノーブレン”J3HG)50部
を島成分とし、ポリスチレン(“スタイロン”666)
46部、ポリプロピレン(住友“ノーブレン”WF−7
27−F)4部の混合物を海成分とする海島型複合繊維
(島数16、単糸繊度2.6デニール、引張強度2.9
g/d、伸度50%、フィラメント数42)50gを、N
−メチロール−α−クロルアセトアミド50g、ニトロ
ベンゼン400g、およびパラホルムアルデヒド0.8
5gからなる混合溶液中に浸し、20℃で1時間反応さ
せた。繊維を反応液から取り出し、0℃の氷水5中に
投じて、反応停止させたのち、水で洗浄し、次に、繊維
に付着しているニトロベンゼンをメタノールで抽出除去
した。この繊維(繊維A)を50℃で真空乾燥して、原
料成型品であるクロルアセトアミドメチル化繊維71g
(繊維A)を得た。Example 1 50 parts of polypropylene (Mitsui "Noblen" J3HG) as an island component and polystyrene ("Stylon" 666)
46 parts, polypropylene (Sumitomo "Noblen" WF-7
27-F) Sea-island type composite fiber containing 4 parts of the mixture as a sea component (16 islands, single yarn fineness 2.6 denier, tensile strength 2.9).
g / d, elongation 50%, filament number 42) 50g, N
-Methylol-α-chloroacetamide 50 g, nitrobenzene 400 g, and paraformaldehyde 0.8
It was immersed in a mixed solution of 5 g and reacted at 20 ° C. for 1 hour. The fiber was taken out of the reaction solution, poured into ice water 5 at 0 ° C. to stop the reaction, washed with water, and then nitrobenzene attached to the fiber was extracted and removed with methanol. This fiber (fiber A) is vacuum dried at 50 ° C., and 71 g of chloracetamide methylated fiber which is a raw material molded product
(Fiber A) was obtained.
アンモニアガスをジメチルスルホキシド中に冷却しなが
ら吹き込んでえた1.8M−アンモニア・ジメチルスル
ホキシド溶液300mlに繊維A20gを加えて、10〜
20℃で72時間反応させた。繊維を取り出し、希塩
酸、および水でよく洗って、本発明担体(繊維B)をえ
た。繊維Bの交換容量は1.15ミリ当量/g、含水率
は繊維1g当りpH4で1.76g、pH7.4で1.
45であった。また、繊維中の第一級アミノ基量はアミ
ノ酸分析の結果、0.96ミリモル/gであった。20 g of fiber A was added to 300 ml of a 1.8 M ammonia-dimethyl sulfoxide solution obtained by blowing ammonia gas into dimethyl sulfoxide while cooling,
The reaction was carried out at 20 ° C for 72 hours. The fiber was taken out and washed thoroughly with dilute hydrochloric acid and water to obtain the carrier of the present invention (fiber B). The exchange capacity of the fiber B is 1.15 meq / g, and the water content is 1.76 g at pH 4 and 1.74 at pH 7.4 per 1 g of fiber.
It was 45. The amount of primary amino groups in the fiber was 0.96 mmol / g as a result of amino acid analysis.
(固定化リポ多糖体の調製) 上記繊維B32gを300mlの水中に一昼夜膨潤させた
のち、Escherichia coli 055:B5のリポ多糖体
(トリクロル酢酸抽出法、ディフコ・ラボラトリーズ社
製造)の0.4mg/ml水溶液500mlと混合し、次に1
N−塩酸および1N−水酸化ナトリウムでpHを4.5
〜6.0に保ちながら、1−エチル−3−(3−ジメチ
ルアミノプロピル)カルボジイミド5.0gを少しずつ
加え、溶解した。この混合物を室温で2日間振とうした
のち、繊維を取り出し、1の沸騰水を中に30分間浸
漬する操作を3回行なった。つぎに、この繊維を0.0
7モルのリン酸緩衝液(pH7.4)で洗浄液のpHが
7.4になるまで洗浄して、リポ多糖体固定化繊維(固
定化リポ多糖体)を得た。上記固定化母液および洗浄液
中のリポ多糖体の濃度をフェノール・硫酸法(試料溶液
1ml+5%フェノール水ml+濃硫酸5ml;485mμ)
で求めた。固定化リポ多糖体中のリポ多糖体固定化量は
5.0mg/gであった。(Preparation of immobilized lipopolysaccharide) After swelling 32 g of the above fiber B in 300 ml of water overnight, 0.4 mg / ml of Escherichia coli 055: B5 lipopolysaccharide (trichloroacetic acid extraction method, manufactured by Difco Laboratories) Mix with 500 ml of aqueous solution, then 1
The pH was adjusted to 4.5 with N-hydrochloric acid and 1N-sodium hydroxide.
While maintaining at -6.0, 5.0 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide was added little by little and dissolved. After shaking this mixture at room temperature for 2 days, the fiber was taken out and the operation of immersing the fiber in boiling water for 30 minutes was repeated three times. Next, add 0.0% of this fiber.
The lipopolysaccharide-immobilized fiber (immobilized lipopolysaccharide) was obtained by washing with 7 mol of phosphate buffer (pH 7.4) until the pH of the washing solution reached 7.4. The concentration of lipopolysaccharide in the above-mentioned immobilized mother liquor and washing solution was determined by the phenol / sulfuric acid method (sample solution 1 ml + 5% phenol water ml + concentrated sulfuric acid 5 ml; 485 mμ).
I asked for. The amount of immobilized lipopolysaccharide in the immobilized lipopolysaccharide was 5.0 mg / g.
実施例2 0℃に冷却した17N−アンモニア水100mlと0℃に
冷却した0〜900mlのN,N−ジメチルホルムアミド
を混合して、アンモニア・DMF溶液をつくった。この
溶液を10℃に冷却し、繊維A3gを加え、10〜20
℃で24hr(比較繊維1をつくるときは10day)反応
させた。繊維を取り出し、希塩酸、および水でよく洗っ
て、本発明担体(繊維C〜H)および比較繊維1を得
た。Example 2 100 ml of 17N-ammonia water cooled to 0 ° C. and 0 to 900 ml of N, N-dimethylformamide cooled to 0 ° C. were mixed to prepare an ammonia / DMF solution. This solution was cooled to 10 ° C., 3 g of fiber A was added, and 10-20
The reaction was carried out at 24 ° C. for 24 hours (10 days when Comparative Fiber 1 was prepared). The fibers were taken out and washed thoroughly with dilute hydrochloric acid and water to obtain the carriers of the present invention (fibers C to H) and comparative fiber 1.
表から非プロトン性極性有機溶媒がないと反応の進みに
くいことがわかる。 From the table, it can be seen that the reaction is difficult to proceed without the aprotic polar organic solvent.
実施例3 新らしく蒸溜したヘキサメチレンジアミンをジメチルス
ルホキシドに溶解し、5,10および20%濃度のヘキ
サメチレンジアミン・DMSO溶液を作った。これらの
溶液(140〜987g)中に繊維A 9.3gを15
℃で加え、その後、15〜25℃で5日間反応させた。
繊維を取り出し、希塩酸、および水でよく洗って、本発
明担体(繊維I〜M)を得た。Example 3 Freshly distilled hexamethylenediamine was dissolved in dimethylsulfoxide to prepare hexamethylenediamine / DMSO solutions having concentrations of 5, 10 and 20%. 15 g of fiber 9.3 g in these solutions (140-987 g)
Then, the mixture was reacted at 15 to 25 ° C for 5 days.
The fibers were taken out and thoroughly washed with dilute hydrochloric acid and water to obtain the carriers of the present invention (fibers I to M).
比較として、ヘキサメチレンジアミン・DMSO溶液の
代りに10%ヘキサメチレンジアミン・水溶液を用いて
同様に処理し、比較繊維2を得た。これら繊維について
の交換容量および含水率の測定結果を表に示す。For comparison, Comparative Fiber 2 was obtained by the same treatment using 10% hexamethylenediamine / water solution instead of the hexamethylenediamine / DMSO solution. The measurement results of the exchange capacity and water content of these fibers are shown in the table.
表から本発明例では官能基がよく導入されているのに対
し、比較例では官能基がほとんど入らないことがわか
る。さらに本発明例では、含水率のpH変化が小さいこ
ともわかる。From the table, it can be seen that the functional groups are often introduced in the examples of the present invention, while the functional groups are hardly introduced in the comparative examples. Further, it can be seen that in the examples of the present invention, the pH change of the water content is small.
実施例4 ドデカメチレンジアミン20gをジメチルスルホキシド
・エタノールの混合溶媒(重量混合比1:1)240g
に溶解し、5℃に冷却後、この中に繊維A6.8gを浸
漬した。混合物を15〜25℃の室温で4日間静置した
のち、繊維を取り出し、希塩酸および水でよく洗って、
本発明担体(繊維N)を得た。交換容量は1.62ミリ
当量/g、含水率はpH4で1.06、pH7.4で
0.72であった。交換容量からドデカメチレンジアミ
ン導入量は0.81ミリモル/gと推定される。 Example 4 20 g of dodecamethylenediamine and 240 g of a mixed solvent of dimethyl sulfoxide / ethanol (weight mixing ratio 1: 1)
And was cooled to 5 ° C., and 6.8 g of the fiber A was immersed therein. After allowing the mixture to stand at room temperature of 15 to 25 ° C. for 4 days, the fibers were taken out, washed thoroughly with dilute hydrochloric acid and water,
The carrier of the present invention (fiber N) was obtained. The exchange capacity was 1.62 meq / g, and the water content was 1.06 at pH 4 and 0.72 at pH 7.4. From the exchange capacity, the amount of dodecamethylenediamine introduced is estimated to be 0.81 mmol / g.
比較として、ジメチルスルホキシド・エタノールの混合
溶媒の代りにエタノールまたはn−ブタノールを用いて
上記と同様の反応を行ったところ、エタノール溶媒のと
きは交換容量0.24ミリ当量/g、含水率0.59
(pH4)、n−ブタノール溶媒のときは交換容量0.
03ミリ当量/g、含水率0.43(pH4)という低
い官能基導入率の繊維しか得られなかった。As a comparison, when ethanol or n-butanol was used in place of the mixed solvent of dimethyl sulfoxide / ethanol and the same reaction was performed, the exchange capacity was 0.24 meq / g and the water content was 0. 59
(PH 4) and n-butanol solvent had an exchange capacity of 0.
Only fibers having a low functional group introduction ratio of 03 meq / g and a water content of 0.43 (pH 4) were obtained.
実施例5 ウンデカメチレンジアミンを10gをジメチルスルホキ
シド190gに溶解し、24℃で、この中に繊維A6.
8gを浸漬した。混合物を10〜20℃の室温で9日間
静置したのち、繊維を取り出し、希塩酸および水でよく
洗って、本発明担体(繊維M)を得た。交換容量は1.
93ミリ当量/g、含水率はpH4で1.0、pH7.
4で0.86であった。交換容量からウンデカメチレン
ジアミン導入量は0.965ミリモル/gと推定され
る。Example 5 10 g of undecamethylenediamine was dissolved in 190 g of dimethylsulfoxide, and at 24 ° C., fibers A6.
8 g was immersed. After allowing the mixture to stand at room temperature of 10 to 20 ° C. for 9 days, the fibers were taken out and washed thoroughly with diluted hydrochloric acid and water to obtain the carrier of the present invention (fiber M). Exchange capacity is 1.
93 meq / g, water content 1.0 at pH 4, pH 7.
It was 0.86 at 4. From the exchange capacity, the amount of undecamethylenediamine introduced was estimated to be 0.965 mmol / g.
比較として、また、繊維A40gを15℃のエチレンジ
アミン中に浸し、15〜20℃の温度で24時間反応さ
せて、エチレンジアミノアセトアミドメチル化繊維(比
較繊維5)を得た。この繊維の交換容量は3.60ミリ
当量/gと高いが、含水率は、pH4で6.2、pH
7.4で1.0と、pHの変動に対し非常に大きく変化
することがわかる。For comparison, 40 g of the fiber A was dipped in ethylenediamine at 15 ° C. and reacted at a temperature of 15 to 20 ° C. for 24 hours to obtain an ethylenediaminoacetamide methylated fiber (comparative fiber 5). The exchange capacity of this fiber is as high as 3.60 meq / g, but the water content is 6.2 at pH 4,
It can be seen that the value is 7.4 at 1.0, which is a very large change with respect to the change in pH.
Claims (2)
官能基を導入した芳香核を有するビニル系重合体からな
る生理活性物質の固定化用担体。 (上式中、R1、R2は水素原子または低級アルキル基
を示し、R3はNH2またはNH−R4−NH2基、R
4は炭素数4以上16以下のアルキレン基を示す)1. A carrier for immobilizing a physiologically active substance, which comprises a vinyl polymer having an aromatic nucleus into which a functional group represented by the following general formula (I) is introduced as a side chain. (In the above formula, R 1 and R 2 represent a hydrogen atom or a lower alkyl group, R 3 represents an NH 2 or NH—R 4 —NH 2 group, R 3
4 represents an alkylene group having 4 to 16 carbon atoms)
能基を導入した芳香核を有するビニル系重合体およびそ
の成型品をアンモニア、 (上式中、R1、R2は水素原子または低級アルキル基
を、Xはハロゲン原子を示す) または下記一般式(III)で示されるジアミンと反応さ
せる際、 NH2−R4−NH2基 (III) (R4は炭素数4以上16以下のアルキレン基を示す) 非プロトン性極性有機溶媒を用いることを特徴とする生
理活性物質の固定化用担体の製法。2. A vinyl polymer having an aromatic nucleus in which a functional group represented by the following general formula (II) is introduced as a side chain and a molded product thereof are ammonia, (In the above formula, R 1 and R 2 are hydrogen atoms or lower alkyl groups, and X is a halogen atom) or NH 2 —R 4 —NH 2 when reacted with a diamine represented by the following general formula (III) Group (III) (R 4 represents an alkylene group having 4 to 16 carbon atoms) An aprotic polar organic solvent is used to produce a carrier for immobilizing a physiologically active substance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60199395A JPH0622628B2 (en) | 1985-09-11 | 1985-09-11 | Carrier for immobilization of physiologically active substance and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60199395A JPH0622628B2 (en) | 1985-09-11 | 1985-09-11 | Carrier for immobilization of physiologically active substance and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6260565A JPS6260565A (en) | 1987-03-17 |
| JPH0622628B2 true JPH0622628B2 (en) | 1994-03-30 |
Family
ID=16407068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60199395A Expired - Lifetime JPH0622628B2 (en) | 1985-09-11 | 1985-09-11 | Carrier for immobilization of physiologically active substance and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0622628B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH112243A (en) * | 1997-06-10 | 1999-01-06 | Nippon Seiko Kk | Lubricant supplier |
-
1985
- 1985-09-11 JP JP60199395A patent/JPH0622628B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6260565A (en) | 1987-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3274844B2 (en) | Solvent and acid stable membranes based on copolymers of acrylonitrile and comonomer | |
| JPH0622628B2 (en) | Carrier for immobilization of physiologically active substance and method for producing the same | |
| EP0568828A2 (en) | Hollow fiber membrane for blood purification | |
| RU2068703C1 (en) | Method of magnoinnune sorbent preparing | |
| US5164475A (en) | Porous substrates with a high concentration of amine groups | |
| JP4032465B2 (en) | Thrombogenic substance adsorbent and extracorporeal circulation column | |
| JPH0122009B2 (en) | ||
| JP2002113097A (en) | Adsorbent and in vitro circulation column | |
| JPH0248044A (en) | Production of chitosan shaped body having anion exchange ability | |
| JP4151802B2 (en) | Production method of polysulfone polymer | |
| JP4182682B2 (en) | Carcinoembryonic antigen adsorbent and extracorporeal circulation column | |
| JPH06102229A (en) | Semipermeable membrane and method for producing the same | |
| JP3584597B2 (en) | Polysulfone polymer and method for producing the same | |
| JP3644117B2 (en) | Modified polysulfone semipermeable membrane and method for producing the same | |
| JP2002035118A (en) | Column for treating inflammatory disease | |
| JPH0526507B2 (en) | ||
| CN101544776B (en) | Preparation method and use of high-density glycosylated polypropylene affinity membranes | |
| JPS63258603A (en) | Aromatic polymer membrane | |
| JPH07165916A (en) | 2-isothiocyanatoacylamidomethylated aromatic polysulfone and its production | |
| JPH0214203A (en) | Aromatic vinyl polymer formed product and production thereof | |
| SU1398901A1 (en) | Method of obtaining organomineral anionite | |
| JPH0236233B2 (en) | ||
| JPS6328453A (en) | Method for producing chitosan molded product with anion exchange ability | |
| WO1994010226A1 (en) | Acylamidomethylated polysulfone and process for producing the same | |
| JPH1033960A (en) | Endotoxin removing membrane and manufacture thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |